Tianjin Medical University Cancer Institute And Hospital

This study is testing a personalized, high-precision radiation treatment for people with early-stage lung cancer who cannot or choose not to have surgery. It aims to see if this targeted approach can control the tumor and help patients live longer over three years while keeping s…

This study looked back at medical records of 800 patients with advanced liver cancer that couldn't be surgically removed. Researchers examined how well patients did when treated with lenvatinib-based drug combinations, tracking survival rates up to 5 years. The goal was to unders…

This study tests whether combining three different types of cancer drugs can help people with advanced colorectal cancer that has stopped responding to standard treatments. Researchers will give patients a targeted therapy, an immunotherapy, and an oral chemotherapy together or i…

This study is testing if adding a new immunotherapy drug called treprizumab to standard chemotherapy before surgery is more effective for treating locally advanced head and neck cancer. It involves 122 patients who are randomly assigned to receive either the new combination or st…

This study is testing whether adding a drug called surufatinib to standard chemotherapy helps people with pancreatic cancer that is difficult to remove with surgery. The goal is to shrink the tumors first to make surgery more successful and improve long-term outcomes. It will inv…

This early-stage study is testing a new cell therapy called GK01, given alongside an existing immunotherapy drug, for people with advanced solid tumors that have spread or returned. The main goal is to check if this combination is safe and how the body processes it, while also lo…

This study is testing a new combination of three drugs—etoposide, anlotinib, and envafolimab—as a first treatment for older adults (65+) with extensive small cell lung cancer. The main goal is to see if this combo is safe and can help control the cancer and delay its progression.…

This study is testing whether combining two drugs, cadonilimab and regorafenib, can help control advanced liver cancer that has continued to grow despite at least one prior treatment. It will involve about 30 adults to see how well the combination works and how safe it is. The ma…

This study is testing whether an artificial intelligence (AI) management system can help reduce anxiety and depression in breast cancer patients who are taking CDK4/6 inhibitor pills at home. It will compare the AI system against standard follow-up care to see which is better at …

This study is collecting and analyzing real-world medical information from 400 elderly patients in China who have Hodgkin lymphoma. The goal is to understand the disease better in this age group and create a tool to help doctors predict how individual patients might fare. The stu…